By Marianne Apostolides
Psilocybin, MDMA, and ketamine can lead to a new sense of self and a release from rigid rules for people with anorexia, bulimia, and binge-eating disorder.
Read on neo.life
CLEAR ALL
After decades of demonization and criminalization, psychedelic drugs are on the cusp of entering mainstream psychiatry, with profound implications for a field that in recent decades has seen few pharmacological advancements for the treatment of mental disorders and addiction.
2
Not long ago The New York Times carried a dispatch from Mexico telling about the descent of hippies on Huautla de Jimenez in quest of the “sacred mushrooms.” With the dispatch appeared a photo of a priestess of the rite, Maria Sabina.
Long before 1960s counter-culture, an indigenous Mexican healer was creating extraordinary poetry under the influence of psychedelic mushrooms.
María Sabina was well-respected in the village as a healer and shaman. She’d been consuming psilocybin mushrooms regularly since she was seven years old, and had performed the velada mushroom ceremony for over 30 years before Wasson arrived.
The benefits of controlled psilocybin use and spiritual practice on people's well-being long outlast the high, researchers find.
Microdosing psilocybin mushrooms can lead to a psychedelic healing experience. The mushroom user can revisit trauma and find new insights.
Research into psychedelics, shut down for decades, is now yielding exciting results.
Scott Atkinson says magic mushrooms have already done much to tame the post-traumatic stress demons conjured by two years serving in Afghanistan and Bosnia.
Regulators will soon grapple with how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.
1
Psychedelic drugs—once promising research subjects that were decades ago relegated to illicit experimentation in dorm rooms—have been steadily making their way back into the lab for a revamped 21st-century-style look.